 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | CD19 UCART cells / China Biotech Services
New P1 trial, CAR T-Cell Therapy: The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL) (clinicaltrials.gov) - Nov 17, 2019
P1, N=20, Recruiting, Sponsor: Shanghai Longyao Biotechnology Inc., Ltd.